Skip to content

+1 877 566 4981

info@fdamap.com

Icon-instagram-1 X-twitter Icon-facebook Icon-linkedin
  • Home
  • About
    • About FDA Map
    • Leadership
    • Testimonials
  • Training
    • Webinars
    • Workshops
    • Custom Training
  • Services
    • Clinical Trial
    • Regulatory Services
    • Project Management
    • FDA Auditing
    • IND Submission
    • NDA Submission
    • 510(k) Submission
    • Quality Assurance
    • Site Certification
  • Insights
    • Blog
    • Articles
    • Press Releases
    • Resources
  • Contact Us
Contact Us
  • Home
  • About
    • About FDA Map
    • Leadership
    • Testimonials
  • Training
    • Webinars
    • Workshops
    • Custom Training
  • Services
    • Clinical Trial
    • Regulatory Services
    • Project Management
    • FDA Auditing
    • IND Submission
    • NDA Submission
    • 510(k) Submission
    • Quality Assurance
    • Site Certification
  • Insights
    • Blog
    • Articles
    • Press Releases
    • Resources
  • Contact Us
Home / Shop / Page 24

Shop

Showing 369–373 of 373 results

  • Your IND Will Fail Unless You Avoid These 7 CMC Mistakes

    Your IND Will Fail Unless You Avoid These 7 CMC Mistakes

    $199.00
    Add to cart
  • ​Technical and Regulatory Writing for FDA-Regulated Industry

    ​Technical and Regulatory Writing for FDA-Regulated Industry

    $1,199.00
    Add to cart
  • ​Technical and Regulatory Writing for FDA-Regulated Industry

    ​Technical and Regulatory Writing for FDA-Regulated Industry

    $3,999.00
    Add to cart
  • ​Technical and Regulatory Writing for FDA-Regulated Industry

    ​Technical and Regulatory Writing for FDA-Regulated Industry

    $7,999.00
    Add to cart
  • ​​Good Clinical Practices and Compliance Issues: Practical GCP

    ​​Good Clinical Practices and Compliance Issues: Practical GCP

    $349.00
    Add to cart
  • ←
  • 1
  • 2
  • 3
  • …
  • 21
  • 22
  • 23
  • 24

Recent Posts

  • Decoding the FDA’s New NGS Safety Framework for the Gene Therapy Products 
  • Mastering the FDA’s New Expanded Access Framework: Expanded Access vs. Right to Try
  • How “Plausible Mechanism” Codifies the Single-Trial Pivot 
  • FDA’s New Risk-Based Inspection Program for Medical Devices: Lessons for Drug Facilities  
  • From In silico to In vivo: Orchestrating AI for Breakthrough Therapeutics

Recent Comments

No comments to show.

One-stop source for FDA consultation, regulatory affairs training, and clinical trial services.

Icon-instagram-1 X-twitter Icon-facebook Icon-linkedin

Services

  • Webinars
  • Workshops
  • On-Demand Webinars
  • Custom training
  • Training Subscriptions

Company

  • About Us
  • Our Client
  • Testimonials
  • Free Resources
  • Newsletter

Support

  • Contact Us
  • Terms of Service
  • Privacy Policy

Payment Method

100% Secure Transaction

Copyright © 2025 FDAMap.com. All rights reserved.